GRX (The Gabelli Healthcare & Wellness Trust) Stock Analysis - SEC Filings

The Gabelli Healthcare & Wellness Trust (GRX) is a publicly traded Financial Services sector company. As of May 21, 2026, GRX trades at $11.52 with a market cap of $131.76M and a P/E ratio of 0.00. GRX moved +0.78% today. Year to date, GRX is -6.05%; over the trailing twelve months it is -6.24%. Its 52-week range spans $8.90 to $11.15. Rallies surfaces GRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find GRX SEC filings?

Rallies organizes GRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

GRX Key Metrics

Key financial metrics for GRX
MetricValue
Price$11.52
Market Cap$131.76M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.17%
52-Week High$11.15
52-Week Low$8.90
Volume3
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest GRX News

Recent GRX Insider Trades

  • GABELLI MARIO J bought 3.80K (~$36.40K) on Jan 12, 2026.
  • GABELLI MARIO J bought 1.01K (~$9.68K) on Jan 12, 2026.
  • GABELLI MARIO J bought 990 (~$9.48K) on Jan 8, 2026.

GRX Analyst Consensus

GRX analyst coverage data. Average price target: $0.00.

Common questions about GRX

Where can I find GRX SEC filings?
Rallies organizes GRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show GRX 10-K and 10-Q filings?
Rallies organizes GRX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is GRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.
GRX

GRX